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In  two  previous  communications  (2,  3)  evidence  was  presented  that  the 
causative  agent  of  primary  atypical pneumonia  (PAP)  associated  with  the 
development of cold agglutinins is a  specific virus. 
This agent was first isolated by Eaton, Meikeljohn, and van Herick (4). The virus 
can be cultivated in chick embryos, where the site of multiplication is confined to the 
bronchial epithelium (2).  Serological studies showed that 68  to 92  per cent of non- 
bacterial pneumonia in several outbreaks was  caused by the PAP virus (3).  More 
recently, Chanock et a2. have reported that 10 per cent of children with various types 
of lower respiratory illnesses had an antibody rise against the PAP vires (5). During 
the  course of the  study on PAP  infections, we have encountered a  factor in fresh 
normal human or guinea pig serum which plays an important role in enhancing the 
serological reactions between the PAP virus and its homologous human convalescent 
serum when tested by the fluorescent antibody staining method. 
The  present paper presents in detail a  study of some of the properties and 
activities of this enhancing factor. 
Materials and Methods 
Virus Strains.--Any strain of the PAP virus may be used for the experiments.  However, 
the experiments  described here were carried out with the F. H. strain isolated in 1955 and 
the Mac strain isolated in 1944 (2). 
Fresh Sera.--Fresh  normal human or guinea pig sera were obtained by centrifugation of the 
clotted blood left at room temperature for 3 to 4 hours  after collection or overnight at 4°C. 
At a dilution of 1/5 these sera did not react with sections of chick embryo lung infected with 
PAP. Satisfactory sera were stored in 0.5 ml. portions in sealed glass tubes in a dry ice box. 
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Stock Solutions.--Veronal  buffer (VB) was prepared as described (6). Additional veronal 
buffer with Ca  ++ and Mg  ++ ions omitted  (VBa) was also prepared. 0.1 ~t ethylenediamine- 
tetraacetate  (EDTA), 0.15 ~t MgSO4, and 0.1 •  CaC12 were prepared by dissolving appro- 
priate salts in VBa. The stock solutions were diluted in VBa as indicated in the protocols. 
The pH of these solutions was between 7.5 and 7.8. 
Sera Lacking Properdin.--The RP and RPb sera were kindly supplied by Dr. R. J. Wedg- 
wood and the late Dr. L. Pillemer of Western Reserve University, Cleveland. The RP serum 
was made from a pool of 50 human sera. RP +  P was the same RP with properdin added to 
2 units per mh 
Removal of Complement by Specific Immune Precipitate. 0.5 mg. protein  nitrogen (N)  of 
specific immune precipitate was prepared by mixing 0.44 mg. antiovalbumin N and 0.06 rag. 
ovalbumin N. The precipitate which formed was washed 3 times with saline. 0.5 ml, of fresh 
normal human or guinea pig serum was mixed with 0.5 rag. N of the washed precipitate and 
was left at 4°C. for 18 hours with occasional agitation. At the end of 18 hours, the serum was 
recovered by centrifugation at 4°C. 
The methods of titration of PAP antibody and scoring of the degree of fluorescent staining 
have already been described (3). 
EXPERIMENTAL RESULTS 
Effect of Fresh Normal Serum on Fluorescent Staining.--It  was noted during 
the course of investigation that the PAP antibody titer of fresh convalescent 
sera determined by fluorescent staining, rarely exceeded a  dilution of  1/80 to 
1//160.  Sera  stored at  -20°C. gradually lost some of  their capacity for fluo- 
rescent staining of the PAP virus and heat inactivation at 56°C. for 30 minutes 
greatly reduced the staining capacity. This heat lability was particularly pro- 
nounced in those late convalescent sera with low antibody titers collected 9 to 
12  months after the patient's recovery, many of which lost their fluorescent 
staining capacity  completely when  heated  at  56°C.  for  30  minutes.  These 
observations suggested  that  a  heat-labile factor  identical with  or  related  to 
complement was playing a role in the fluorescent staining reaction, and investi- 
gation along this line was begun. 
A series of sections from a  known PAP-infected chick embryo lung was cut 
and each slide was treated with various combinations of reagents as listed in 
Table I. It can be seen that in line A, which shows those sections that were 
treated  with  fresh  normal human or  guinea pig  serum at  1/5  dilution and 
fluorescent anti-human globulin rabbit serum,  no  staining of  the  PAP virus 
was visualized. However, when the sections were treated with a  1/10 dilution 
of fresh human PAP convalescent serum collected from a  patient 12  months 
after infection, a  strong staining reaction was seen as shown in line B.  When 
the same convalescent serum was inactivated by heat at 56°C. for 30 minutes 
or was treated with a  specific immune precipitate, no fluorescent staining was 
seen as shown in lines C and D. The addition of fresh normal human or guinea 
pig  serum  to  these  heat-inactivated or  precipitate-treated sera  restored  the 
fluorescent staining as seen in lines E  and H.  However,  heat-inactivated or 
precipitate-treated fresh normal sera failed to do so as in lines F, G, and I. cHrEN  LIU  113 
To prove that  some serum factor in the fresh sera by its own virtue did not 
mediate  fluorescent  staining  on  the  PAP  virus,  further  staining  experiments 
were carried out (Table II). It can be seen from lines A  to D  that hyperimmune 
TABLE  I 
Effect of Fresh Normal Serum on Fluorescent Staining of PAP Virus with 
Human Convalescent Serum 
A. Normal fresh human or G.P. serum at 1/5 dilution .........................  0 
B. Fresh PAP convalescent serum at 1/10 ....................................  +++ 
C. Heat inactivated PAP convalescent serum* at 1/10 .........................  0 
D. Decomplemented PAP convalescent serum:~ at 1/10 .........................  0 
E. "C" +  fresh normal human or G.P. serum at  1/10 ..........................  +++ 
F.  "C" +  inactivated normal human or G.P. serum ...........................  0 
G. "C" +  decomplemented normal human§ or G.P. serum .....................  0 
It. "D" +  fresh normal human or G.P. serum ................................  +++ 
I.  "D" +  decomplemented normal human or G.P. serum  .....................  0 
* Heated at 560C. for 30 minutes. 
0.5 rnl serum treated with precipitates of ovalbumin-antiovalbumin  containing 0.5 mgm. 
of protein N  at 4°C. overnight. 
§ Before treatment with precipitate, serum contain 143 100 per cent hemolytic units/mh 
Mter treatment with precipitate, serum contained <  25 units/ml. 
TABLE II 
Effect of Fresh Normal Serum (FNS) on Fluorescent Staining of PAP Virus wlth Homologous 
Hyperimmune Rabbit Serum 
A. Fresh rabbit PAP serum (1/10)  -1- No.  188" ...............................  -t--l-+ 
B. Inactivated (56°C./30 rain.) rabbit PAP serum (1/10) -t- No.  188 .............  -1-++ 
C. Inactivated rabbit PAP serum (1/10)  +  FNS:~ -t- No.  188 ...................  +-t-+ 
D. Inactivated rabbit PAP serum (I/10) -t- inactivated FNS +  No.  188 .........  ++-t- 
E. Fresh rabbit PAP serum (1/10)  +  No.  187§ ...............................  0 
F.  Inactivated rabbit PAP serum (1/10) +  No.  187 ...........................  0 
G. Inactivated rabbit PAP serum (1/10)  +  FN8 -1- No.  187 ....................  0 
H. Inactivated rabbit PAP serum (1/10)  +  inactivated FNS  -t- No. 187 .........  0 
I.  FNS alone -t- No. 188 ...................................................  0 
J.  FNS alone -t- No.  187 ...................................................  0 
* No.  188, fluorescent anti-rabbit globulin goat serum. 
:~ FNS,  fresh normal human serum. 
§ No.  187, fluorescent anti-human globulin rabbit serum. 
rabbit  PAP  serum gave good fluorescent staining of the virus with or without 
the addition of fresh normal serum if the reactions were carried out with fluo- 
rescent  anti-rabbit  globulin.  However,  no fluorescent  staining was  detected  if 
fluorescent anti-human  globulin was employed as in lines E  through H. This is 
especially significant in line G  which indicates that presumably  the guinea pig 
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the combination of the rabbit PAP antibody with the PAP virus, yet such a 
condition did  not give any fluorescent  staining  with  fluorescent  anti-human 
globulin. This suggested that neither guinea pig nor human complement per se 
would give a non-specific fluorescent staining of the PAP virus. The alternative 
is that in this PAP antigen-antibody system, complement is not fixed.  It has 
been reported (7)  that the complement fixed in antigen-antibody reaction can 
be detected by fluorescent antibody staining. 
Enhancing  Effect  of Fresh Normal  Serum  on  Fluorescent  Staining  of PAP 
Virus.--Table III lists eight pairs of human PAP sera to illustrate the enhanc- 
ing effect of fresh normal serum (FNS) on fluorescent staining. The first four 
pairs  of  sera  showed  that  there  was  a  marked  increase  in  the  convalescent 
TABLE III 
Enhancing Effea of Fresh Normal Serum (FNS) on Antibody Titer of PAP Fluorescent  Staining 
Fresh Serum, no FNS added  Inactivated  serum +  FNS 
Patient 
Convalescent 
Co T, 
R.J. 
O.G. 
S. 
F.D. 
R. P. H. 
E.W. 
F.H. 
Acute  Convalescent 
<10  80* 
< 10  80 
<10  160 
< 10  20 
<10  160 
<10  10 
80  40 
< 10  20 
<10 
20 
<10 
<10 
640 
20 
>640 
<10 
Acute 
320 
640 
640 
>320 
1280 
40 
80 
160 
* Reciprocal of serum dilution. 
serum titer when FNS was added for titration. Patient F. D.'s sera illustrated 
an apparent increase in titer during convalescence when the sera were titrated 
without the addition of FNS. Actually this patient already had a titer of 1/640 
when the first serum was obtained on the 8th day of his illness,  when FNS was 
added to the serum before titration. Patients R. P. H. and F. H. did not show 
a definite rise of antibody titer when titrated without addition of FNS, yet one 
showed a definite rise (F. H.) and the other (R. P. H.) did not, when FNS was 
employed. Patient E. W. did not show much of a drop of antibody in the second 
serum collected 4 months after his illness.  However, when FNS was added the 
drop was more than 8-fold. 
The enhancing effect of the FNS on indirect fluorescent staining was found 
to be in the first step when unlabeled serum was put in contact with the virus 
and  not  in  the  second  step  when  the  fluorescent  anti-human  globulin  was 
added.  When  the  fluorescein-labeled  anti-PAP  human  serum  was  used  for 
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intensity that the procedure was not satisfactory for detecting the PAP viral 
antigen. Addition of FNS for direct fluorescent staining did not increase the 
visual intensity of the viral antigen. 
Effect of FNS on  Indirect Staining of Other Viral Systems.--When  rabbit 
hyperimmune PAP serum was used in place of human PAP convalescent serum 
to stain the PAP virus in infected chick embryo lung sections, the addition of 
FNS had no enhancing effect on the antibody titer. When human sera from 
influenza A  and B,  mumps,  and measles infections were used  to react with 
corresponding  viruses  in  infected  chick  embryo  chorio-allantoic  membrane 
TABLE IV 
Effect of Addition  of Fresh Normal Serum  (FNS) to Immune Sera in the Indirect  Ftuorescent 
Staining  of Chick Embryo  Tissues lnfeaed with  Viruses 
Patient 
R.D. 
G. 
Pool 
Serum* 
Rabbit hyperimmune PAP 
Human acute influenza A' 
Human convalescent influenza A' 
Human acute influenza B 
Human convalescent influenza B 
Human convalescent mumps 
Human convalescent measles 
Titer 
No FNS  Added FNS 
4OO  2OO 
<4O  <40 
640  64O 
<40  <40 
1280  1280 
320  320 
160  320 
* All sera inactivated at 56°C. for 30 minutes. 
sections by the same indirect fluorescent staining procedure, addition of FNS 
also did not show any enhancing effect (Table IV). 
Effect of Various Durations of Contact of FNS on Fluorescent Staining of PAP 
Virus.--In  order to investigate the  effect of the duration of contact of the 
FNS factor on the fluorescent staining,  the following experiment was carried 
out. A series of sections from a chick embryo lung infected with PAP virus was 
cut. Each of these sections was treated for 30 minutes with a  1/80 dilution of 
heat-inactivated human serum from a  patient convalescent from PAP infec- 
tion. Equal volumes (about 0.05 ml.) of fresh normal human serum diluted to 
1/5 with veronal buffer were added to the slides at various intervals during 
this  reaction period.  The results  showed  that  while  the  convalescent serum 
alone at this dilution without the addition of FNS did not give any staining of 
the PAP virus, the presence of FNS for 1 minute in the convalescent serum 
was  enough to  give a  positive reaction.  However, maximum staining  of the 
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Effect of the Dilution  of FNS  on Staining.--To  find out the relative amount 
of FNS required to enhance the activity of human PAP antibody, 2-fold dilu- 
tions of a  heat-inactivated convalescent serum were made in various dilutions 
of  FNS.  As shown in Table VI,  the  antibody titers were  comparable in the 
TABLE V 
Effect  of  Time of Addition  of FNS  to  Serum  on  PAP  Virus Staining 
Method.--Fresh  normal human serum  (FNS) was diluted at  1/5  with one drop of PAP 
serum on slide, then one drop of FNS was added at various intervals. 
A. Added immediately ................................... 
B. Added 10 min. after serum ............................. 
C. Added 20 rain. after serum ............................. 
D. Added 25 min. after serum ............................. 
E. Added 27 rain. after serum ............................. 
F. Added 29 re.in, after serum ............................. 
G. None ................................................ 
Time of contact  Staining 
m~. 
30 
20 
10 
5 
3 
1 
0 
+++* 
+++ 
+++ 
+++ 
++ 
+ 
0 
* +++,  maximal fluorescent staining. 
+ +, moderate. 
+, minimal. 
TABLE VI 
Effect of Dilution  of FNS on ttte Staining  of PAP Virus 
Serum dilution* 
FNS dilution 
1/20  1/40  11320  1/640 
1/10 
1/20 
1/40 
1/80 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
++ 
1~o  1/16o 
+++  +++ 
+++  +++ 
+++  +++ 
+  + 
++ 
++ 
+ 
± 
+ 
+ 
-4- 
-4- 
* Fresh  normal serum  (FNS)  was made into various dilutions in veronal buffer. PAP 
convalescent serum was diluted in the FNS solution. 
titrations made in FNS dilutions between 1/10 and 1/40. There was a  definite 
drop of the serum titer when it was titrated in the 1/80 dilution of FNS. This 
result is in agreement with the previous observation that antibody titrations of 
PAP convalescent sera rarely exceeded 1/80 or 1/160 dilution which apparently 
is owing to the presence of a limited amount of the enhancing factor in the sera. 
Effect of Properdin on Fluorescent Staining  Reactions.--The  properdin system 
has activity in destroying bacteria (8) and inactivating  viruses (9). The activitv 
of properdin depends on the presence of all four components of  complement CmEN  ~  117 
and the Mg++ ion (10). As shown in Table VII, fresh human serum lacking 
properdin (RP) was just as efficient as fresh normal human serum in enhancing 
the fluorescent staining reaction. The RP serum was prepared from a pool of 50 
human sera which did contain a trace of PAP antibody as seen in lines H  and 
TABLE  VII 
Effect  of Properdin  on Fluorescent Staining of PAP Virus 
Conditions  Staining 
A. Heat inactivated PAP serum ......................................... 
B. "A" q- fresh normal human serum~ .................................... 
C. "A" +  inactivated normal human serum ................................ 
D. "A" -1- fresh RP ..................................................... 
E. "A" +  fresh (RP q- P) ............................................... 
F. "A" -1- inactivated RP  at 56  ° for 30 min  ................................ 
G. "A" q- inactivated (RP +  P) at 56* for 30 rain  .......................... 
H. Fresh RP at 1/10 .................................................... 
I.  Fresh (RP q- P) at 1/10 .............................................. 
J.  Inactivated RP at 1/10.. 
K. Inactivated (RP q- P) at 1/10 ......................................... 
O* 
+++§ 
0 
+++ 
+++ 
0 
0 
+11 
+ 
0 
0 
* O, no specific fluorescence. 
Final dilution of added reagents was 1/10. 
§ W-F-F, very strong specific fluorescence. 
[1 -k, minimal specific fluorescence. 
TABLE VIII 
Inhibition  of Fluorescent Staining  of PAP  Virus by  EDTA 
Tubes 
PAP serum, ml  ......... 
Undiluted  human  FNS. 
fnt .................  i 
EDTA (0.005 M), ml  .... 
Veronal buffer, ml  ....... 
Fluorescent staining .... 
A 
0.1 
0.1 
0.07 
0.73 
+++ 
B 
0.1 
0.1 
0.08 
0.72 
+++ 
C 
0.1 
0.1 
0.09 
0.71 
+++ 
D 
0.1 
0.1 
0.1 
0.70 
0 
E 
0.1 
0.1 
0.11 
0.69 
0 
F 
0.1 
0.1 
0.12 
0.68 
0 
G 
0.1 
0.1 
0.8 
+++ 
H 
0.1 
0.9 
0 
I. However, the intensity of the specific fluorescence owing to this trace of anti- 
body was much weaker in comparison with those seen in lines B, D, and E, in 
which the RP was used as enhancing factor. The difference was unequivocally 
clear. Heat inactivation of RP or FNS abolished the enhancing effect. 
Inhibition of FNS Activity by EDTA.--It  has been shown by Levine et al. 
(11)  that  the hemolytic activity of complement  requires the presence of  Ca  ++ 
and Mg++ ions and that EDTA  abolishes it. In order to test the effect of EDTA 
on  the  enhanced  staining  effect  conferred  by  normal  serum,  heat-inactivated c~ 
~  o  c,  I  !  I  ~  -t- 
r~  6  e,  ~  6  ~  6~  ~ 
~  e,  o  o  6~  6  -b 
1 
/ 
+ 
c~  c~  c~  c~  6 
co 
,C  c~ 
/ 
r 
4- 
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PAP human convalescent serum was diluted to such a degree that only in the 
presence of fresh normal human serum could a positive staining of the virus be 
obtained.  EDTA in varying concentrations were  added  to each  tube  (Table 
VIII).  The  only  available  Ca++  and  Mg  ++  ions  in  the  medium  were  con- 
tributed from the PAP convalescent serum,  the FNS, and  the chick embryo 
lung tissue.  The result was that EDTA at a  final concentration of 0.0005  M 
completely inhibited the staining reaction. 
Reversal of EDTA Inhibition by Addition of Ca  ++ and Mg++ Ions.--In Table 
IX, it is shown that the addition of Ca++ ion alone in a final concentration of 
50/zM or Mg++ ion alone at a final concentration of 30 #~ restored the staining 
TABLE  X 
Effect of Different Complement Fractions on Fluorescent Staining  of PAP Virus with Human 
Convalescent Serum 
Experiment ......  A  B 
PAP serum, ml... 
FNS, m/... 
RI, ml.. 
R2, ml.. 
1~, rot.. 
R~, ml.. 
Veronal buffer, m/. 
--  0.  I 
0.1  0.  I 
__  M 
1.C  0.9 
Degree of fluorescence A ....  0  +q-+ 
B .....  0 /+++* 
I 
CDEFG 
R11 R2  Ra  R4  Rt 
R2 
0.1!0.1  0.10.1  0.1 
0.5  0.5 
--0.5  --.--  0.5  --.-- 
--I-  0.1  --  -- 
--I--'-  0.5 
0.5!0.5  0.90.5  0 
I 
o  0  ++o  4- 
0  o  ++  o  ++ 
H  I  J  K  L 
R1  R~  Rt  R~  Rs 
Rs  R~  :  R~  R~  R4 
I ....... 
0.10.11  0.10.1  0.1 
! 
0.50.51 
0.50.5 
0.1  --I 0.1  --  0.1 
0.51-  0.5  0.5 
0.4  0  0.4  0  0.4 
o/+++ o 
M 
!0. 
!I.( 
0 
0 
* The FNS control was not from the same sera in the complement fractions, since these 
fractions were made from several different sera. 
activity. However, when both Ca  ++ and Mg  ++ were present, considerably less 
Ca  ++ and Mg  ++ ions were needed.  The experiment was designed so that the 
total concentration of Ca  ++ and Mg  ++ ions added together was 20 #~. It can 
be seen that maximum restoration of fluorescent staining could be achieved at 
a concentration of Ca++ ion between 10 and 12 #~ and Mg  ++ between 8 and l0 
pM.  Concentration of Mg++ below 8 ~  gave poor or no fluorescent staining 
even when Ca++ was increased to 19 ~.  On the other hand, with Mg++ over 
8 #M, as little as 1/z~ of Ca++ gave a fairly strong fluorescent staining. 
Effect of Complement  Fractions  on Fluorescent Staining.--Since the enhancing 
factor had so many properties similar to complement it was logical to extend 
the comparison further in seeing whether these two substances were identical. 
If it were complement, then fractions lacking one of the components of comple- 
ment should be ineffective and combinations of these fractions should restore 
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Two batches of fresh normal human sera were used in preparing the complement reagents. 
In Experiment A, the serum was the FNS used in previous experiments. In Experiment B, 
the materials were from Dr. R. J. Wedgwood's laboratory at Western Reserve University, 
Cleveland. Among  these reagents, R1 and R~ were made from a single serum. R3 was made from 
a pool of 25 sera and R4 was made of serum from an individual not the donor of R1 and R2. 
Preparation of the complement reagents was carried out according to the method of Kabat 
and Mayer (12) with modifications (13). The effect of individual fractions and combinations 
of them on the specific fluorescent staining of PAP virus is summarized in Table X. 
In both experiments, it can be seen that when Rz, R~, or R4 was used alone, 
no enhancing activity was present. However, R3 had a  good enhancing effect. 
In the combinations of reagents, both experiments gave similar results except 
that in Experiment A, combination of R1% R2 had equivocal activity while in 
Experiment B  it had  good activity. Other than  this  discrepancy,  the  results 
were almost identical:  combinations containing  R3  (e.g.  R1 q-  R3,  R~ -k  R3, 
and R3 -t- R~) were active, while R1 ~  R4 and R~ q-  R4 were completely inac- 
tive. 
DISCUSSION 
The  serum factor that  has an enhancing  effect on  the  fluorescent staining 
reaction between the PAP virus and its human convalescent serum has many 
properties  similar to  complement. The  factor is heat-labile,  is  removable by 
specific immune precipitate,  and  is  dependent  on  the  presence  of  Ca  ++  and 
Mg  ++ ions for its activity. Since R1,  R~, or t~ alone was non-reactive while 
R3 was reactive, this suggests that probably C'~, C'2, and C'4 are essential for 
the activity,  but C'3 is  not  essential.  It is  quite  certain  that  the  enhancing 
factor is  not  properdin,  because  the  serum lacking  properdin  (RP)  had  full 
enhancing activity. It should be noted here that in the preparation of R3 and 
RP,  there  is a  similarity in  the  method in  which  zymosan was added  to  the 
serum. 
Contrary to our anticipation,  all six combinations of  R1,  R2,  R3,  and  1~ 
did not  give us full enhancement of activity. In the  R1  ~  R2 recombination 
Experiment A  had very little if any activity while experiment B  had moder- 
ately good activity.  Since  R~ itself was quite  active, it would be anticipated 
that the recombinations containing R3 such as R~ ~- R3, R2 ~  R3, and R3 -t- R4 
would also be active. The significant fact here was that Rz q- R4 and R2 q- R4 
did not have any activity at all in both experiments. 
We  are  aware  that  the  present  data  cannot  give  any definite  conclusions 
concerning the identity of the enhancing factor. If the factor is a part of comple- 
ment, then C'1,  C'~, and Ct~ are the essential components while C'3 is not.  On 
the other hand,  each of the six combinations should contain all four comple- 
ment  components.  By hemolysis of  sensitized  sheep  cells,  more than  75  per 
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these fractions, yet the enhancing activity was gone or equivocal except in the 
combinations in which R3 was present.  This raised the question whether there 
could be a separate serum factor other than properdin  and complement which 
was responsible for the enhancement of the fluorescent  staining.  This factor 
could well depend on the presence of C'1, C~, and C~, and Ca  ++ and Mg  ++ ions 
to mediate its function. However, all the procedures used in fractionating the 
complement  components,  except the process of adding zymosan to the serum 
for preparing  R8  or  properdin,  had  a  detrimental effect  on  this  enhancing 
factor, particularly the process of preparing  R, by hydrazine. With the tech- 
nical  advancement in the purification  of individual complement  components 
in progress, it may be possible to use purified fractions in the future to elucidate 
the identity of this enhancing factor. 
There is no explanation why this enhancing  property occurred  only in the 
reactions between the PAP virus and the human PAP convalescent serum, but 
not between  the same virus and its homologous hyperimmune rabbit serum 
nor in the other virus-serum  systems tested by the fluorescent antibody stain- 
ing technic: Mumps, measles, and influenza A and B. A similar enhancement 
of antibody titer of fluorescent staining of the simian foamy virus by adding 
fresh normal guinea pig serum to the foamy virus antiserum has been described 
by Carski  (14). Sabin  (15) has shown that in the serum neutralization test of 
dengue  virus  a  complement-like  factor greatly enhances  the  neutralization 
index.  Also, in the toxoplasma  dye test complement  and properdin play an 
important role (16). The factor exerts its enhancing effect during the time when 
the PAP virus is combining  with the unlabeled  antibody molecules and not 
during the time when  the antibody molecules combine  with the fluorescent 
anti-globnlin serum.  Furthermore, the amount of the factor needed  for the 
enhancing  activity was quite small, of the order of 2 units or less of comple- 
ment, and the time required  for it to be present as short as a  few minutes. 
Therefore,  it is possible that the factor may act as a catalyst to increase the 
deposition of antibody molecules on the viral antigen, or it may help to form a 
firmer  union between  the antigen-antibody complex preventing the washing 
away of antibody molecules during the various steps  of fluorescent  staining 
procedures. 
Although we realize that there are a number of basic questions  concerning 
this  enhancing  phenomenon which  cannot  be  answered  at  this  time,  this 
enhancing factor has helped us greatly in the serological studies of PAP infec- 
tion. The addition of fresh  normal serum to the test not only increases  its 
sensitivity without affecting its specificity; it also provides  a means to study 
sera that have been stored for long periods of time or sent into the laboratory 
without proper refrigeration. 122  PRIMARY  ATYPICAL  PNEII~ONIA.  III 
S~RY 
A  factor present in fresh normal human or guinea pig serum enhances the 
primary atypical pneumonia (PAP) antibody fiters in serological reaction with 
its homologous virus as tested by indirect fluorescent antibody staining. This 
factor is not properdin. It has many properties similar to complement but may 
not be identical with complement. The addition of this enhancement factor to 
human  sera  convalescent  from  primary  atypical  pneumonia  has  made  the 
serological test more sensitive without affecting its specificity. 
The author gratefully acknowledges the kind generosity of Dr. R. J. Wedgwood and the 
Late Dr. L. Pillemer of Western Reserve University, Cleveland, in supplying much of the 
serum fractions for this investigation. The author is indebted to Dr. Albert H. Coons of the 
Harvard Medical School for his help in the preparation of the fluorescent antibody solutions 
and for his helpful criticisms and encouragement. The able technical assistance of Mrs. Susan 
Chapman, Mrs.  Sarah Barnett,  and  Mrs. Eleanor Sharp is also gratefully acknowledged. 
BIBLIOGRAPHY 
1.  Liu, C., and Heyl, J. T., Serological study of primary atypical pneumonia, Fed. 
Proc.,  1957, 16, 423. 
2.  Liu,  C.,  Studies  on primary atypical pneumonia I. Localization, isolation,  and 
cultivation of a virus in chick embryos, J. Exp. Med., 1957, 106,455. 
3.  Liu, C., Eaton, M. D., and Heyl, J. T., Studies  on primary atypical pneumonia 
II.  Observations  concerning  the  development  and  immunological  charac- 
teristics of antibody in patients, J. Exp. Med., 1959, 109,545. 
4.  Eaton, M. D., Meikeljohn,  G., and van Herick, W., Studies  on the etiology of 
primary atypical pneumonia. I. A filterable agent transmissible to cotton rats, 
hamsters and chick embryos, J. Exp. Med.,  1944, 79, 649. 
5.  Chanock, R. M., Cook, M. K., Fox, H. H., Parrott, R. H., and Huebner, R. J., 
Serologic evidence of infection with Eaton agent in lower respiratory illness in 
childhood,  New England J. Med.,  1960, 262, 3. 
6.  Osier, A. G., Strauss, J. H., and Mayer, M. M., Diagnostic complement fixation. 
I. A method, Am. J. Syph., 1952, 36, 140. 
7.  Goldwasser,  R. A., and Shepard, C. C., Staining  of complement and modification 
of fluorescent  antibody procedures,  J. Imrnunol., 1958, 80, 122. 
8.  Wardlaw, A. C., and Pillemer,  L., The properdin system and immunity. V. The 
bactericidal activity of the properdin system, J. Exp. Med., 1956, 108, 553. 
9.  Wedgwood,  R. J., Ginsberg,  H. S., and Pillemer,  L., The properdin system and 
immunity. VI. The inactivation of Newcastle disease  virus by the properdin 
system, J. Exp. Med., 1956, 104,707. 
10.  Pillemer, L., The properdin system, Ann. New York Acad. Sc., 1955, 17, 536. 
11.  Levine, L., Cowan, K. M., Osier, A. G., and Mayer, M. M. Studies on the role of 
Ca  ++ and Mg  ++ in complement fixation and immune hemolysis. I. Uptake of 
complement nitrogen by specific  precipitates  and  its  inhibition  by  ethylene 
diamine tetra acetate, J. Immunol.,  1953, 71, 359. 
12.  Kabat, E. A., and Mayer, M. M., Experimental  Immunoehemistry, Springfield, 
Illinois,  Charles C. Thomas, 1st edition,  1948, 121. cm~N  LIU  123 
13.  Wedgwood,  M.  D.,  Measurement  of  the  components  of complement  by  the 
reagent titration technique, Z. Imrauni~gtsforsch., 1959, 118, 358. 
14.  Carski,  T.  R.  A  Fluorescent Antibody Study of the Simian  Foamy Agent.  J. 
Immunol.,  1960, 84, 426. 
15.  Sabin, A. B., The dengue group of viruses and its family relationships,  Baderiol. 
Rev., 1950, 14, 225. 
16. Feldman, H. A. The relationship of toxoplasma antibody activator to the serum. 
properdin system, Ann. New York Acad. So.,  1956, 66, 263. 